SIRPA and neoplasm: Anyway, disruption of the SIRPα-CD47 axis can also activate adaptive immune responses, including amplifying the presentation of tumor-derived antigens to CD8+ T cell [67], or enhancing NK cell-modulated ADCC and complement-dependent cytotoxicity (CDC), thus alleviating suppression of the innate immune system [68].